Richard Manning Email & Phone Number

Boston, Massachusetts, Us

Chicago, Il, Us

Paris, France, Fr

Assumed leadership of Dupixent Patient Services during a period of transition and multiple launches. Immediately implemented enhancements to streamline processes and create efficiencies resulting in an improved patient experience.- Implemented a new patient services model that reduced FTE needs by 400 and operating expenses by $100M. Resulted in over $1B in anticipated OPEX savings over the strategic planning period.- Onboarded a new Dupixent Commercial Copay partner and successfully blunted PBM copay accumulator and maximizer strategies, saving the organization in excess of $350M annually and ensuring 100% of Sanofi’s Dupixent commercial copay support went directly to the patient.- Exceeded, by 250%, the goal to increase % of Dupixent patients converting to therapy within 90 days. - Established an irresistible culture across the Dupixent Patient Services Alliance by focusing on selfcare, empathetic collaborative working relations & fun. Resulted in a less than 2% annual regrettable attrition rate.- Ensured Patient Services was prepared for and could support four Dupixent product launches in two years.- Facilitated the fourfold expansion of the Field Reimbursement Team ensuring each of Dupixent’s disease states received the direct support they need, resulting in more patients on therapy.- Hired a best-in-class Dupixent Patient Services Management Team post Sanofi’s assuming responsibility of Dupixent Patient Services from Regeneron in 2021.- Anticipated future Dupixent Patient Services needs and proactively coordinated the expansion and reorganization of the Dupixent Patient Services team to ensure those future needs were met immediately when needed.

Paris, France, Fr

Led the Neurology Patient Support Services Team setting the strategic direction to achieve the businesses commercial objectives. Created, maintained, and continually enhanced patient offerings across the patient journey to include the considering, starting, and staying on therapy stages. - Guided the Neurology team through a rescoping of roles & responsibilities and a reduction in field support maintaining the patient & people focus and strong Sanofi Genzyme culture. - Proposed and implemented patient services model enhancements for the Neurology brands to improve the customer experience, get patients on product quickly, and reduce costs. Customer satisfaction scores with MS121 improved in 10+% while operating expenses were reduced by 50%.- Navigated the sudden closure of Lemtrada’s REMS home phlebotomy lab vendor by leveraging existing relationships resulting in the achievement of 100% patient compliance to the Lemtrada REMS lab requirement.

Paris, France, Fr

Assumed leadership of the Multiple Sclerosis Field Reimbursement Manager (FRM) team to help members become subject matter experts in billing, coding, claims, procurement, contracting and access issues for Lemtrada and Aubagio. Motivated and guided the team to execute the national strategy and support the initiatives established by the business. - Managed the team through significant disruption when the entire leadership team was replaced in late 2015. - Advocated for and received approval to expand the FRM team twofold, allowing increased focus and greater patient access.

Paris, France, Fr

Asked to build and assume leadership of the newly formed Market Access Operations group. Managed all operational activities related to the new Payer Account Management team and the existing Payer and Channel Marketing team. - Designed various tools, systems, and templates that significantly increased department effectiveness. - Established strong, trusting cross-functional relationships between Sanofi’s many business units resulting in strong collaboration, coordination, and best practice sharing.

Paris, France, Fr

Post-acquisition of Genzyme by Sanofi joined the Multiple Sclerosis business unit tasked with creating the new Patient Services program, MS One to One, in advance of the launch of Aubagio and Lemtrada. - Operationalized and launched the Aubagio and Lemtrada Commercial Co-Pay, Patient Assistance and Starter Rx programs and created the MS One to One training program for the newly hired Aubagio & Lemtrada Sales Force. - Led the MS One to One Lemtrada build and the development, negotiation, management, and monitoring of the Lemtrada REMS program. Collaborated cross-functionally as part of the Lemtrada US Launch Team, comfortably navigating through the complexity and ambiguity of a product launch. - Refined and enhanced MS One to One’s service offering resulting in 95% of patients reporting highly satisfied with MS One to One services and 96% reporting plans to recommend MS One to One to other MS patients.

Paris, France, Fr

Promoted to manage the $350M US OTC and distribution business, the physician and GPO contracting program, and all wholesaler/specialty pharmacy relationships. Managed relationship between Genzyme and its 3rd party logistics provider, ICS, and 3rd party returns processor, GenCo. Developed, implemented, and maintained physician and GPO rebate contracting program, including managing two direct reports who oversaw the administration of 350 physician and 12 GPO contracts. - Reduced physician/GPO contract rebate payment turnaround times from 180+ days to less than 45 days.- Created a compliant first-of-its-kind Leukine Sampling program and enhanced customer satisfaction by reducing paperwork and streamlining the ordering process.- Negotiated two Wholesaler Regional Distribution Center Agreements saving the business approximately $250K in annual packaging and freight cost.

Paris, France, Fr

Identified need for transition to new 3rd party US logistics supplier and was promoted and tasked with leading the RFP process, choosing the new supplier, and creating and leading the transition team. Monitored and maintained US drug product inventory levels by scheduling production cycles based on current and future sales forecasts.- Transitioned Campath, Fludara, and Leukine from Bayer. Ensured visibility to channel inventory levels by negotiating 31 wholesaler inventory management agreements. Transition completed within 90 days with no interruption to business.- Reduced yearly order to cash and distribution costs by ~$2M by identifying and transitioning the business to Integrated Commercialization Solutions.

Paris, France, Fr

Hired to complete complex administrative projects during the 2004 ILEX acquisition and integration. Promoted and tasked with developing, implementing, and maintaining the business unit’s sales operations standard operating procedures.

Master Of Science (Ms), Project Management

Bachelor Of Arts (Ba), History